Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1816705 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Qian-Qian Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Medical University, School of Public Health, Department of Epidemiology and Biostatistics, Center for Big Data and Population Health of IHM, He…. Hauptthemen laut MEDLINE: Osteoarthritis, Feces, Metabolome, Gastrointestinal Microbiome. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Globally, Osteoarthritis (OA) represents a primary chronic joint condition, rooted in complex mechanisms such as metabolic irregularities, synovitis, immune system responses, and body-wide inflammation. Emerging evidence highlights gut microbiota as a critical mediator of joint inflammation.
Methods
In this study, 55 OA patients from the affiliated hospital of Anhui Medical University were compared with 55 healthy controls. Using 16S rRNA (V4–V5) sequencing and POS/NEG dualionmode untargeted fecal metabolomics, we investigated the "gutmetabolismimmunityjoint" axis in OA.
Results
The results indicate that patients with OA exhibit significant gut microbiota dysbiosis, characterised in particular by a reduction in beneficial bacterial groups such as Clostridiales , Lactobacillales , Bacilli and Actinobacteria, and an increase in Bacteroidaceae and Burkholderiales . Metabolomic analysis revealed that metabolic pathways such as beta-alanine metabolism and pyrimidine metabolism were enriched. Specific microbial changes are associated with alterations in host metabolism, for example, a reduction in the beneficial bacteria Actinobacteria was positively correlated with the downregulation of indole-3-acetic acid, which has a beneficial effect; Bacilli and Lactobacillales were associated with the dual loss of luteolin and D-tryptophan.
Discussion
This study revealed significant alterations in gut microbiota and fecal metabolites in OA patients compared to healthy individuals. The identified differential metabolites hold promise as potential biomarkers for early diagnosis or therapeutic targets, offering new insights for future personalized interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Medical University, School of Public Health, Department of Epidemiology and Biostatistics, Center for Big Data and Population Health of IHM, Hefei, Anhui, China.
- Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zitieren
APA
Zhou, Q. Q., Wang, J., Zhang, L. L., He, Y. T., Liu, H., Cao, Y. G., Cheng, L., Zhang, Y. Q., Zhang, L., Wang, Y. Y., Lu, Z. W., & Li, B. Z. (2026). Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1816705
Vancouver
Zhou QQ, Wang J, Zhang LL, He YT, Liu H, Cao YG, et al. Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1816705
BibTeX
@article{Zhou2026,
author = {Zhou, Qian-Qian and Wang, Jing and Zhang, Li-Lan and He, Ya-Ting and Liu, Hao and Cao, Yang-Guang and Cheng, Lin and Zhang, Ya-Qin and Zhang, Lei and Wang, Yi-Yuan and Lu, Zhang-Wei and Li, Bao-Zhu},
title = {Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1816705}
}
EUVIMED